Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 7 |
NetGPI | no | yes: 0, no: 7 |
Term | Name | Level | Count |
---|---|---|---|
GO:0005737 | cytoplasm | 2 | 2 |
GO:0032991 | protein-containing complex | 1 | 2 |
GO:0110165 | cellular anatomical entity | 1 | 2 |
GO:1990904 | ribonucleoprotein complex | 2 | 2 |
Related structures:
AlphaFold database: Q4Q941
Term | Name | Level | Count |
---|---|---|---|
GO:0003676 | nucleic acid binding | 3 | 8 |
GO:0003723 | RNA binding | 4 | 8 |
GO:0003729 | mRNA binding | 5 | 2 |
GO:0005488 | binding | 1 | 8 |
GO:0097159 | organic cyclic compound binding | 2 | 8 |
GO:1901363 | heterocyclic compound binding | 2 | 8 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_PCSK_SKI1_1 | 118 | 122 | PF00082 | 0.314 |
CLV_PCSK_SKI1_1 | 166 | 170 | PF00082 | 0.279 |
DEG_Nend_UBRbox_2 | 1 | 3 | PF02207 | 0.653 |
DEG_SCF_TRCP1_1 | 40 | 45 | PF00400 | 0.624 |
DOC_CYCLIN_RxL_1 | 115 | 122 | PF00134 | 0.514 |
DOC_MAPK_gen_1 | 139 | 148 | PF00069 | 0.497 |
DOC_WW_Pin1_4 | 178 | 183 | PF00397 | 0.519 |
LIG_14-3-3_CanoR_1 | 118 | 127 | PF00244 | 0.547 |
LIG_FHA_1 | 199 | 205 | PF00498 | 0.497 |
LIG_FHA_2 | 148 | 154 | PF00498 | 0.546 |
LIG_LIR_Nem_3 | 122 | 127 | PF02991 | 0.543 |
LIG_LIR_Nem_3 | 78 | 82 | PF02991 | 0.578 |
LIG_PAM2_1 | 6 | 18 | PF00658 | 0.644 |
LIG_SH2_CRK | 165 | 169 | PF00017 | 0.514 |
LIG_SH2_CRK | 79 | 83 | PF00017 | 0.575 |
LIG_SH3_3 | 11 | 17 | PF00018 | 0.644 |
LIG_SH3_3 | 197 | 203 | PF00018 | 0.543 |
LIG_TRAF2_1 | 150 | 153 | PF00917 | 0.514 |
MOD_CK1_1 | 137 | 143 | PF00069 | 0.514 |
MOD_CK1_1 | 198 | 204 | PF00069 | 0.506 |
MOD_CK1_1 | 38 | 44 | PF00069 | 0.635 |
MOD_CK1_1 | 65 | 71 | PF00069 | 0.603 |
MOD_CK2_1 | 147 | 153 | PF00069 | 0.514 |
MOD_CK2_1 | 188 | 194 | PF00069 | 0.492 |
MOD_GlcNHglycan | 121 | 124 | PF01048 | 0.308 |
MOD_GlcNHglycan | 190 | 193 | PF01048 | 0.496 |
MOD_GlcNHglycan | 40 | 43 | PF01048 | 0.654 |
MOD_GlcNHglycan | 44 | 47 | PF01048 | 0.615 |
MOD_GlcNHglycan | 64 | 67 | PF01048 | 0.620 |
MOD_GlcNHglycan | 8 | 11 | PF01048 | 0.670 |
MOD_GSK3_1 | 153 | 160 | PF00069 | 0.505 |
MOD_GSK3_1 | 178 | 185 | PF00069 | 0.504 |
MOD_GSK3_1 | 31 | 38 | PF00069 | 0.689 |
MOD_LATS_1 | 29 | 35 | PF00433 | 0.678 |
MOD_N-GLC_1 | 137 | 142 | PF02516 | 0.314 |
MOD_N-GLC_1 | 182 | 187 | PF02516 | 0.478 |
MOD_N-GLC_1 | 6 | 11 | PF02516 | 0.637 |
MOD_N-GLC_1 | 62 | 67 | PF02516 | 0.584 |
MOD_NEK2_1 | 85 | 90 | PF00069 | 0.635 |
MOD_NEK2_1 | 96 | 101 | PF00069 | 0.527 |
MOD_NEK2_2 | 157 | 162 | PF00069 | 0.514 |
MOD_PIKK_1 | 19 | 25 | PF00454 | 0.632 |
MOD_PIKK_1 | 209 | 215 | PF00454 | 0.570 |
MOD_PIKK_1 | 35 | 41 | PF00454 | 0.730 |
MOD_PKB_1 | 164 | 172 | PF00069 | 0.514 |
MOD_Plk_4 | 65 | 71 | PF00069 | 0.603 |
MOD_ProDKin_1 | 178 | 184 | PF00069 | 0.515 |
TRG_ENDOCYTIC_2 | 124 | 127 | PF00928 | 0.543 |
TRG_ENDOCYTIC_2 | 165 | 168 | PF00928 | 0.514 |
TRG_ENDOCYTIC_2 | 79 | 82 | PF00928 | 0.641 |
TRG_ER_diArg_1 | 55 | 58 | PF00400 | 0.666 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1I044 | Leptomonas seymouri | 71% | 94% |
A0A3Q8IC83 | Leishmania donovani | 96% | 99% |
A4HF08 | Leishmania braziliensis | 87% | 99% |
A4I287 | Leishmania infantum | 95% | 99% |
E9AYD2 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 95% | 100% |
Q4Q6X2 | Leishmania major | 32% | 100% |